← Back to Clinical Trials
Recruiting NCT06915649

NCT06915649 Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06915649
Status Recruiting
Phase
Sponsor University Hospital, Montpellier
Condition Hippocampal Sclerosis
Study Type OBSERVATIONAL
Enrollment 3,504 participants
Start Date 2024-08-31
Primary Completion 2025-09

Trial Parameters

Condition Hippocampal Sclerosis
Sponsor University Hospital, Montpellier
Study Type OBSERVATIONAL
Phase N/A
Enrollment 3,504
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2024-08-31
Completion 2025-09
Interventions
Amygdalo-Hippocampectomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this retrospective study is to evaluate the long-term clinical outcomes and complications associated with amygdalo-hippocampectomy using the surgical technique developed by Pr. Coubes (Montpellier, FRANCE). The main questions it aims to answer are: * What are the complications and evolution of clinical outcomes in patients treated with this technique for hippocampal sclerosis or other intern temporal diseases ? * What variables are associated with better seizure control following surgery? Participants include 234 patients treated over the last 30 years at the CHU de Montpellier, FRANCE. The study will analyze clinical data, including seizure outcomes based on ILAE criteria, post-operative complications, and factors influencing recovery and reintegration into daily life.

Eligibility Criteria

Inclusion Criteria: * Patients who had undergone an Amygdalo-Hippocampectomy according to the surgical procedure that we describe Exclusion Criteria: * Patients who did not have this exact procedure.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology